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SINTESIS DAN PENCIRIAN HIDROKSIAPATIT (HA)  
DAN HIDROKSIAPATIT DITUKARGANTI SILIKON (Si-HA)  
YANG DIHASILKAN MENERUSI KAEDAH MENDAK 
 
ABSTRAK 
Pemendakan adalah suatu kaedah yang berjaya untuk menghasilkan 
hidroksiapatit (HA) dan hidroksiapatit ditukarganti silikon (Si-HA) berketulenan 
tinggi pada suhu rendah. Dalam kajian ini, kalsium hidroksida [(Ca(OH)2] dan asid 
fosforik (H3PO4) telah dipilih sebagai bahan mula untuk menghasilkan HA. Sewaktu 
sintesis, tindakbalas telah dilakukan secara pengadukan laju pada beberapa parameter 
berlainan. Serbuk HA yang terhasil telah dikalsin pada suhu 700, 850, 1000, dan 
1200oC selama 1 jam. Keputusan menunjukkan HA berketulenan tinggi dan stabil 
sehingga 1200oC telah berjaya dihasilkan bila tempoh penuaan dipanjangkan ke 24 
jam. Bahan mula yang berlainan kepekatan, yakni 0.5, 1.0, 1.5 dan 2.0 M telah juga 
dikaji. Keputusan menunjukkan bahawa zarah HA bersaiz nano berjaya diperolehi 
pada semua kepekatan manakala HA stoikiometri tulen dengan kestabilan terma 
sehingga 1200 oC diperolehi pada kepekatan 0.5 dan 1.0 M. 
  
Berasaskan keadaan optimum yang diperolehi dalam sintesis HA, kaedah 
mendak turut digunakan untuk menghasilkan HA yang ditukarganti silikon pada 
paras 0.4, 0.8 dan 1.6 % berat silikon menggunakan silikon asetat [Si(OCOCH3)4] 
sebagai sumber Si. Serbuk/pelet HA dan Si-HA yang dihasilkan telah dikalsin pada 
suhu kalsin berlainan, iaitu 1150, 1200 dan 1250oC. Keputusan menunjukkan bahawa 
Si-HA tulen telah berjaya dihasilkan pada ketiga-tiga paras silikon. Si-HA tulen pada 
paras 0.4 dan 1.6 % berat Si telah diperolehi pada semua suhu kalsin manakala Si-
xvi 
 
HA pada paras 0.8 % berat Si telah mengurai kepada α-TCP pada suhu 1250oC. 
Kesan silikon ke atas HA adalah dengan mengaruh peningkatan kecil parameter 
kekisi struktur apatit secara anjakan kecil corak XRD sampel Si-HA. Selain itu, 
silikon di dalam hidroksiapatit mengekang penumpatan pada suhu rendah (1150oC) 
dan kesan ini menjadi semakin ketara bila paras penukargantian silikon meningkat. 
Ketumpatan hampir sempurna (> 90 %) telah diperolehi bagi HA tulen pada 1200oC 
manakala sampel Si-HA mencecah ketumpatan ini pada 1250oC. Pemerhatian SEM 
jelas menunjukkan penukargantian silikon juga merencat pertumbuhan butir pada 
suhu-suhu tinggi (1200 dan 1250oC). Perencatan tumbesaran butir meningkat bila 
kandungan silikon meningkat. Pada ketumpatan hampir sempurna, nilai kekerasan 
sampel Si-HA mencecah nilai setanding dengan sampel HA. Walau bagaimanapun, 
kekuatan lebih tinggi diperolehi bagi sampel Si-HA dan ini mencapai nilai tertinggi 
15.93 MPa pada suhu 1250oC bagi sampel yang mengandungi 1.6 % silikon.   
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SYNTHESIS AND CHARACTERIZATION OF HYDROXYAPATITE (HA) 
AND SILICON SUBSTITUTED HYDROXYAPATITE (Si-HA)  
PRODUCED BY A PRECIPITATION METHOD 
 
ABSTRACT 
The precipitation method is a successful route to synthesize high purity 
hydroxyapatite (HA) and silicon-substituted hydroxyapatite (Si-HA) at low 
temperatures. In this research, calcium hydroxide (Ca(OH)2) and phosphoric acid 
(H3PO4) were chosen as starting materials to synthesize HA. During synthesis, the 
reaction was carried out under vigorous stirring at various parameters. As-prepared 
HA powders were calcined at different temperatures of 700, 850, 1000 and 1200oC 
for 1 hour. The results indicated that high purity HA was obtained and is stable up to 
1200oC when the aging time is prolonged to 24 hours. Different concentrations of 
reactants, viz. 0.5, 1.0, 1.5 and 2.0 M were also studied. The results indicated that 
nano-size HA particles were obtained at all the concentrations whereas pure 
stoichiometric HA with high thermal stability of up to 1200oC was obtained at 
concentration of 0.5 and 1.0 M.  
 
Based on the optimum conditions which were investigated in the synthesis of 
HA, the precipitation method was again employed to synthesize silicon-substituted 
HA with silicon contents of 0.4, 0.8 and 1.6% by weight using silicon acetate 
[Si(OCOCH3)4] as the Si source. The as-prepared HA and Si-HA powders/pellets 
were calcined at different calcination temperatures of 1150, 1200 and 1250oC. The 
results showed that pure Si-HA samples were successfully prepared at all three 
silicon contents. At all the calcination temperatures, pure Si-HA at silicon content of 
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0.4 and 1.6 wt% was obtained whilst Si-HA at silicon content of 0.8 wt% 
decomposed into α-TCP at 1250oC. The effect of silicon in HA induced a slight 
increase in lattice parameters of apatite structure resulting in slight shifting of XRD 
pattern of Si-HA samples. In addition, the silicon in hydroxyapatite inhibited 
densification at low temperature (1150oC) and this effect being more significant as 
the level of silicon substitution increased. A near-full density (>90%) was achieved 
in pure HA at 1200oC whilst the Si-HA sample reached this density at 1250oC. SEM 
observation clearly showed that silicon substitution also inhibited grain growth at 
high temperatures (1200 and 1250oC). The inhibition of grain growth increased as 
the silicon content increased. At a nearly full density, the hardness value of Si-HA 
sample reached the comparable value with HA sample. However, higher strength 
was achieved in Si-HA samples, and this reached a highest value of 15.93 MPa at 
1250oC for sample prepared at 1.6 % of silicon. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Introduction 
Many millennia ago, the discovery by human kind that fire would irreversibly 
transform clay into ceramic pottery led eventually to an agricultural society and an 
enormous improvement in the quality and length of life. Within the last four decades 
another revolution has occurred in the use of ceramics to improve the quality of life. 
This revolution is the innovative use of specially designed ceramics for the repair and 
reconstruction of diseased or damaged parts of the body. Ceramics used for this 
purpose are termed bioceramics, which may be bioinert (e.g., alumina and zirconia), 
resorbable (e.g., tricalcium phosphate), bioactive (e.g., hydroxyapatite, bioactive 
glassed, and glass ceramics) or porous for tissue ingrowth (e.g., hydroxyapatite-
coated metals). Applications of bioceramics include replacement for hips, knees, 
teeth, tendons and ligaments, as well as repair for periodontal disease, maxillofacial 
reconstruction, augmentation and stabilization of the jaw bone, spinal fusion and 
bone repair after tumor surgery (Hench, 1998). 
 
Calcium phosphate-based bioceramics have been in use in medicine and 
dentistry for nearly 20 years (Hench et al., 1998). Among the different calcium 
phosphates, hydroxyapatite (HA), Ca10(PO4)6(OH)2, is the most important 
bioceramic used in dentistry and orthopedic surgery. Crystalline hydroxyapatite is a 
synthetic material analogous to calcium phosphate found in bone and teeth and a 
highly compatible material that has been considered for coating on metallic implants, 
as a porous ceramic that facilitates bone ingrowths, an inorganic component in a 
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ceramic-polymer composite, a granulate to fill small bone defects and for tissue 
engineering scaffolds (Maria and Daniel, 2005). Over the last two decades, numerous 
efforts have been made to prepare hydroxyapatite for bone tissue applications due to 
its excellent biocompatibility and bioactivity (Kothapalli et al., 2004).  
 
1.2  Problem statement 
The resorption property of calcium phosphates depends on Ca/P ratio, degree 
of crystallinity and crystal structure. A remarkable property of the synthetic HA is its 
bioactivity, in particular the ability to form chemical bonding with surrounding hard 
tissues after implantation (Fathi et al., 2008). However, most synthetic apatites are 
formed via high temperature processes (e.g. sintering), resulting in a well-crystallized 
structure, which has little or no activity toward bioresoption. 
 
To produce synthetic HA powders with the desired properties, wet-chemical 
methods (precipitation, hydrothermal technique, and hydrolysis of other calcium 
phosphate) and dry processes (solid-state reaction) can be used. Other methods for 
the preparation of HA powders have also been reported: sol-gel (Feng et al., 2005), 
microwave irradiation (Meejoo et al., 2006), emulsion processing (Koumoulidis et al, 
2003), and mechanochemical treatment. Depending upon the technique, materials 
with various morphology, stoichiometry and level of crystallinity can be obtained. 
The solid state reaction usually give a stoichiometric and well-crystallized product 
but they require relatively high temperatures and long duration of heat-treatment 
(Mobasherpour et al., 2007) whilst the sol-gel method involved molecular mixing of 
the calcium and phosphorous resulting in chemical homogeneity, but has drawbacks 
such as the possible hydrolysis of the phosphates and the high cost of raw materials. 
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Also, the HA prepared by this method resulted in relatively inferior crystallinity and 
thermal stability (Kothapalli et al., 2004). 
 
In general, the wet-chemical methods allow the production of materials with 
good crystallinity, physiological stability and with the morphological characteristics 
of the hard tissue, but some of the physical, chemical and mechanical properties of 
the final products usually depend on the specific method used in the synthesis. 
(Donadel et al., 2005). The choice of precipitation method to produce HA in this 
research work can result in calcium phosphate material produced with a low-cost 
technique, simple and versatile using low temperature under atmosphere condition. 
Separately, during the reactions, the reaction media involves no foreign elements 
except water, the only by product. For these reasons, it is of great importance to 
develop inexpensive HA synthesis methods focused on the precise control of particle 
size, morphology and chemical composition (Binnaz et al., 2009).  
 
However, even if the biocompatibility of HA is excellent, the bioactive 
process in HA shows some drawbacks when compared with other bioactive 
materials. For instance, the bioactivity reactions in silica based glasses occur in a few 
minutes, whereas those in HA take several days. It is believed that the bioactive 
behavior of HA can be improved by introducing some substitutions in the structure 
(Palard et al., 2008). The apatite structure can incorporate a wide variety of ions, 
which affect both its cationic and anionic sublattices (Maria and Daniel, 2005). The 
most common example of this is the substitution of carbonate ions into the HA 
structure (Gibson et al., 2001; Lafon et al., 2007) such that the product contains 3 to 
8 wt% carbonate, which is similar to the levels detected in bone mineral. Other ions, 
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which are found in bone mineral, have been substituted into the HA structure, such 
as magnesium (Yasukawa et al., 1996), fluorine (Jha et al., 1997) and sodium, 
although their role on the biological performance of HA has not been clearly 
established (Gibson et al., 2002). 
 
It was found that, silicon in small quantities has a significant effect on the 
development and growth of hard tissue of living bodies (Best et al., 2001). 
Particularly, synthetic calcium phosphate-based materials including 0.1% to 5% by 
weight of Si clearly demonstrate improved biological performances in terms of 
enhanced bone apposition, bone ingrowth and cell-mediated degradation. It has been 
suggested that, despite comparable dislocation density, Si-HA ceramics undergo 
faster dissolution, occurring preferentially around grain boundaries and triple 
junctions (Bianco et al., 2009). Thus, the sintering of ceramics made of substituted 
HA incorporating silicate (SiO44-) was investigated. There are not so many 
researches up to date that have been done on the synthesis of silicon-substituted 
hydroxyapatite (Si-HA). Most of the researches focused on the synthesis of 
carbonated hydroxyapatite or K, Na substituted hydroxyapatite. Moreover, the 
synthesis of pure Si-HA powders has always been a difficulty. Not so many 
researchers succeeded in preparing pure silicated hydroxyapatite using different 
processes. In addition, the calcination behavior of Si-HA as well as its mechanical 
properties were rarely considered. 
 
The synthesis of HA by a precipitation method in present study based on the 
study of Lazic et al., (2001), Afshar et al., (2003), Saeri et al., (2003) and Mostafa et 
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al., (2005), using  Ca(OH)2/H3PO4 system. The optimum process parameters was 
used to further synthesized Si-HA with Si(OCOCH3)4 as a silicon source. 
 
1.3 Objective of research 
The aim of this research is to synthesize single phase hydroxyapatite (HA) 
and silicon substituted hydroxyapatite (Si-HA) powders with high thermal stability 
by a precipitation process and comparing the physical and mechanical properties of 
HA and Si-HA obtained. With this main object, the following studies were 
conducted: 
 
1. Synthesis of HA and Si-HA by a precipitation method and characterizing 
the physical and mechanical properties. 
2. Investigation on the effect of silicon on the formation of HA. 
 
1.4 Research scope 
In general, the research work is divided into two parts which will be 
described in details in chapter 3. The first part is the synthesis and characterization of 
HA using a wet precipitation method with Ca(OH)2 and H3PO4 as starting materials. 
The precipitation process parameters such as stirring speed, reaction temperature, 
aging time and concentration of reactants were investigated. Based on these optimum 
process parameters, the second part is the synthesis of silicon substituted HA with 
Ca(OH)2, H3PO4 and Si(OCOCH3)4 as precursors. The characterization technique 
includes XRD, SEM, FTIR, TEM, TG/DSC. The density and specific surface area 
were measured. The mechanical properties of HA and Si-HA pellets were 
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determined by using Vickers hardness test and diametral tensile strength.  Figure 1.1 
and Figure 1.2 illustrate generally the methodology in this research. 
 
 
H3PO4 solution Ca(OH)2 solution
Reaction 
Filtering and washing
Drying 
As-prepared powder
Calcination 
Calcined- powder
Powder characterization
Powder characterisation
Suspension in the 
mother solution
 
 
Figure 1.1 Flow chart for the synthesis of hydroxyapatite 
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Figure 1.2 Flow chart for the synthesis of Si-HA and properties comparison between 
HA and Si-HA 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.0  Introduction  
The use of bone substitutes in human surgery has dramatically increased over 
the last few decades. These materials have been used to guide and expand the bone 
healing tissue, to become intergrated within it and then subjected to the same 
remodeling process as the natural bone (Frayssinet, 1998). However, the available 
amount of proper bones substitution is generally limited and the implantation 
requires a second operation which is very painful (Neumann, 2006). Therefore, there 
is high demand for the synthetic bone substitution material. 
 
In recent years, synthetic hydroxyapatite has been extensively used as the 
synthetic bone substitution material due to its excellent biocompatibility and its 
similar characteristics with biological bone. However, the bioactivity behavior of 
hydroxyapatite can be improve by introducing Si ions to produce Si-HA which 
resembles bone tissue composition. Consequently, a number of studies have been 
focused on the production of synthetic HA and Si-HA ceramic for bone substitutes. 
 
This review chapter provides an overview of biomaterials. The topic on 
bioceramic material, as a part of biomaterials, will be explained in more detail. As 
HA and Si-HA are the calcium phosphate based bioceramics, the properties of these 
bioceramics are presented in this chapter. This is followed with a review of previous 
synthesis of HA and Si-HA by other researchers. 
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2.1  Biomaterials 
Biomaterials is a term used to indicate materials that constitute part of 
medical implants and disposables that have been utilized in medicine, surgery, 
dentistry and veterinary medicine as well as in every aspect of patient health care 
(Hench and Wilson, 1998). A biomaterial is a synthetic material used to replace part 
of a living system or to function in intimate contact with living tissue. The Clemson 
University Advisory Board for Biomaterials has formally defined a biomaterial to be 
“a systemically and pharmacologically inert substance designed for implantation 
within or incorporation with living systems” (Wong and Bronzino, 2007). 
 
Biomaterials can broadly be classified as biological biomaterials (soft and 
hard tissue type) and synthetic biomaterials (metallic, polymeric, ceramic and 
composite biomaterials). Each type of synthetic biomaterial has advantages and 
disadvantages in properties as well as processibility and was exploited for different 
specific applications. Some examples of biomaterials are provided in Table 2.1. 
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Table 2.1: Materials for use in the body (Wong and Bronzino, 2007) 
Material Advantages Disadvantages Examples 
Polymer (nylon, 
silicone rubber, 
polyester, 
polytetrafuoroethylene, 
etc.) 
 
Resilient 
Easy to fabricate 
Not strong 
Deform with time 
May degrade 
Sutures, blood 
vessels, hip 
socket, 
ear, nose, other 
soft tissues, 
sutures 
Metals (Ti and its 
alloys, Co-Cr alloys, 
stainless steels, Au, 
Ag, Pt, etc.) 
 
Strong, tough, 
ductile 
May corrode, 
dense, difficult to 
make 
Joint 
replacements, 
bone plates 
and screws, 
dental root 
implants, pacer 
and suture wires 
Ceramics (aluminum 
oxide, calcium 
phosphates including 
hydroxyapatite, 
carbon) 
 
Very 
biocompatible, 
inert, strong in 
compression 
 
Brittle, not 
resilient, 
difficult to make 
 
Dental; femoral 
head of hip 
replacement, 
coating of dental 
and orthopedic 
implants 
Composites (carbon-
carbon, wire or fiber 
reinforced bone 
cement) 
Strong, tailor-
made 
Difficult to 
fabricate 
Joint implants, 
heart valves 
 
2.2  Types of Synthetic Biomaterials 
In general, synthetic biomaterial can be classified into three groups namely 
metallic biomaterials, ceramic biomaterials and polymer biomaterials. The details 
will be discussed in the following sections. 
2.2.1  Metallic biomaterials 
Metals have been used almost exclusively for load-bearing implants, such as 
hip and knee prostheses, fracture fixation wires, pins, screws and plates (Dee et al., 
2002). Metals are also used as biomaterials due to their excellent electrical and 
thermal conductivity and mechanical properties. Since some electrons are 
independent in metals, they can quickly transfer an electric charge and thermal 
energy. The mobile free electrons act as the binding force to hold the positive metal 
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ions together. This attraction is strong, as evidenced by the closely packed atomic 
arrangement resulting in high specific gravity and high melting points of most metals 
(Wong and Bronzino, 2007). 
 
The mechanical properties of materials are of great importance when 
designing load-bearing orthopedic and dental implants. Some mechanical properties 
of metallic biomaterials are listed in Table 2.2. With a few exceptions, the high 
ultimate tensile and fatigue strength of metals, compared to ceramic and polymers 
make them the materials of choice for implants that carry mechanical loads. 
 
Table 2.2: Selected properties of metallic biomaterials (Dee et al., 2002) 
Materials Young’s 
modulus, E 
[GPa] 
Yield 
strength,  
σy [MPa] 
Tensile 
strength, 
σUTS [MPa] 
Fatigue limit, 
 σend [MPa] 
Stainless steel 190 221-1,213 586-1,351 241-820 
Co-Cr alloys 210-253 448-1,606 655-1,896 207-950 
Titanium 110 485 760 300 
Ti-6Al-4V 116 896-1,034 965-1,103 620 
Natural bone 15-30 30-70 70-150 - 
 
The elastic moduli of the metals listed in Table 2.2 are at least seven times 
greater than that of natural bone. This mismatch of mechanical properties can cause 
“stress shielding”, a condition characterized by bone resorption (loss of bone) in the 
vicinity of implants. This clinical complication arises because the preferential 
distribution of mechanical loading through the metallic prosthesis deprives bone of 
the mechanical stimulation needed to maintain homeostasis. 
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2.2.2  Ceramic and glass biomaterials 
Ceramics are defined as the art and science of making and using solid articles 
that have as their essential component, inorganic nonmetallic materials (Kingery et 
al., 1976). Ceramic are refractory, polycrystalline compounds, usually inorganic, 
including silicates, metallic oxides, carbides and various refractory hydrides, 
sulfides, and selenides. Oxides such as Al2O3, MgO, SiO2 and ZrO2 contain metallic 
and nonmetallic elements and ionic salts, such as NaCl, CsCl, and ZnS. Exceptions 
to the preceding include covalently bonded ceramics such as diamond and 
carbonaceous structures like graphite and pyrolized carbons (Park and Lakes, 1992). 
 
In recent years, humans have realized that ceramics and their composites can 
also be used to augment or replace various parts of the body, particularly bone. Thus, 
the ceramics used for the latter purposes are classified as bioceramics. Their relative 
inertness to the body fluids, high compressive strength, and aesthetically pleasing 
appearance led to the use of ceramics in dentistry as dental crowns. 
 
Unlike metals and polymers, ceramics are difficult to shear plastically due to 
the ionic nature of the bonding and minimum number of slip systems. These 
characteristics make the ceramics brittle and are responsible for almost zero creep at 
room temperature. Consequently, ceramics are very susceptible to notches or 
microcracks because instead of undergoing plastic deformation, they will fracture 
elastically on initiation of a crack. At the crack tip the stress could be many times 
higher than the stress in the material away from the tip, resulting in a stress 
concentration which weakens the material considerably. The latter make it difficult 
to predict the tensile strength of the ceramic. This is also the reason ceramics have 
13 
 
low tensile strength compared to compressive strength. If a ceramic is flawless, it is 
very strong even when subjected to tension (Park and Lakes, 1992). 
 
Ceramics are generally hard; in fact, the measurement of hardness is 
calibrated against ceramic materials. Diamond is the hardest, with a hardness index 
of 10 on Moh’s scale, and talc (Mg3Si3O10COH) is the softest ceramic, while 
ceramics such as alumina (Al2O3), quartz (SiO2) and apatite (Ca5P3O12F) are in the 
middle range. Other characteristic of ceramic materials are (1) their high melting 
temperature and (2) low conductivity of electricity and heat. These characteristics are 
due to the chemical bonding within ceramics (Wong and Bronzino, 2007). 
 
The desired properties of implantable bioceramics are (Wong and Bronzino, 
2007): 
- Non-toxic 
- Non-carcinogenic 
- Non-allergic 
- Non-inflammatory 
- Biocompatible 
- Biofunctional for its lifetime in the host 
 
Ceramics used in fabricating implants can be classified as nonabsorbable 
(relatively inert), bioactive or surface reactive (semi-inert) and biodegradable or 
resorbable (non-inert). Alumina (Al2O3), zirconia (ZrO2), silicon nitrides (Si3N4) and 
carbons are inert bioceramics. Certain glass ceramics and dense hydroxyapatites are 
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semi-inert (bioreactive) and calcium phosphates and calcium aluminates are 
resorbable ceramic (Wong and Bronzino, 2007). 
 
Ceramics and glasses are used as components of hip implants, dental implant, 
middle ear implants, and heart valves. Overall, however, these biomaterials have 
been used less extensively than either metals or polymers. Some ceramics that have 
been used for biomedical application are listed in Table 2.3. 
 
Table 2.3: Ceramics used in biomedical applications (Dee et al., 2002) 
Ceramics Chemical formula Remarks 
Alumina Al2O3 Bio-inert 
Zirconia ZrO2 Bio-inert 
Pyrolytic carbon  Bio-inert 
Bioglass Na2O.CaO.P2O3-SiO2 Bioactive 
Hydroxyapatite (sintered 
at high temperature) 
Ca10(PO4)6(OH)2 Bioactive 
Hydroxyapatite (sintered 
at low temperature) 
Ca10(PO4)6(OH)2 Biodegradable 
Tricalcium phosphate Ca2(PO4)3 Biodegradable 
 
The major drawbacks to the use of ceramics and glasses as implants are their 
brittleness and poor tensile properties (see Table 2.4). Although they can have 
outstanding strength when loaded in compression, ceramics and glass fail at low 
stress when loaded in tension or bending. Among the biomedical ceramics, alumina 
has the highest mechanical properties, but its tensile properties are still below those 
of metallic biomaterials. Additional advantageous properties of alumina are its low 
coefficient of friction and wear rate. From these properties, alumina has been used as 
a bearing surface in joint replacements. 
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Table 2.4: Mechanical properties of ceramic biomaterials (Dee et al., 2002) 
Materials 
Young’s 
Modulus, E 
(GPa) 
Compressive 
Strength, (MPa) 
Tensile 
Strength, 
(MPa) 
Alumina 380 4500 350 
Bioglass-ceramics 22 500 56-83 
Calcium phosphates 40-117 510-896 69-193 
Pyrolytic carbon 18-28 517 280-560 
 
The mechanical properties of calcium phosphates and bioactive glasses make 
them unsuitable as load-bearing implants. Clinically, hydroxyapatite has been used 
as a filler for bone defect and as an implant in load-free anatomic sites (for example, 
nasal septal bone and middle ear). In addition, hydroxyapatite has been used as a 
coating on metallic orthopedic and dental implant to promote their fixation in bone. 
In these cases, the underlying metal carries the load, whereas the surrounding bone 
strongly bonds to the hydroxyapatite. 
 
2.2.3  Polymeric biomaterials 
Synthetic polymeric materials have been widely used in medical disposable 
supply, prosthetic materials, dental materials, implants, dressings, extracorporeal 
devices, encapsulants, polymeric drug delivery systems, tissue engineered products, 
and orthodoses as that of metal and ceramic substituents. The main advantages of the 
polymeric biomaterials compared to metal or ceramic materials are ease of 
manufacturability to produce various shapes (latex, film, sheet, fibers, etc.), ease of 
secondary processablility, reasonable cost and availability with desired mechanical 
and physical properties. The required properties of polymeric biomaterials are similar 
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to other biomaterials, that is, biocompatibility, sterilizability, adequate mechanical 
and physical properties, and manufacturability as given in Table 2.5 (Wong and 
Bronzino, 2007). 
 
Table 2.5: Requirement for Biomedical Polymers (Wong and Bronzino, 2007) 
Properties Description 
Biocompatibility 
Noncarcinogenesis, nonpyrogenicity, nontoxicity, and 
nonallergic response 
Sterilizability Autoclave, dry heating, ethylenoxide gas, and radiation 
Physical property Strength, elasticity, and durability 
Manufacturability Machining, molding, extruding, and fiber forming. 
   
The mechanical properties of polymers depend on several factors, including 
the composition and structure of the macromolecular chains and their molecular 
weights. Table 2.6 lists some mechanical properties of selected polymeric 
biomaterials. Compared with metals and ceramics, polymers have much lower 
strengths and moduli but they can be deformed to a greater extent before failure. 
Consequently, polymers are generally not used in biomedical applications that bear 
loads (such as body weight). Ultra high molecular weight polyethylene (UHMWPE) 
is an exception, as it is used as a bearing surface in hip and knee replacements. The 
mechanical properties of polymers, however, are sufficient for numerous biomedical 
applications (some of which are listed in Table 2.6). 
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Table 2.6: Mechanical properties of biomedical polymers (Dee et al., 2002) 
Polymer 
Tensile 
Strength, 
MPa 
Young’s 
Modulus, E, 
MPa 
Elongation, 
% 
Polymethylmetacrylate 
(PMMA) 
30 2.2 1.4 
Nylon 6/6 76 2.8 90 
Polyethylene terephthalate 53 2.14 300 
Polylactic acid 28-50 1.2-3 2-6 
Polypropylene 28-36 1.1-1.55 400-900 
Polytetrafluoroethylene 17-28 0.5 120-350 
Silicone rubber 2.8 Up to 10 160 
Ultra high molecular weight 
polyethylene (UHMWPE) 
≥35 4-12 ≥300 
 
 
2.3  Calcium phosphate ceramics 
Calcium phosphate-based bioceramics have been in used in medicine and 
dentistry for nearly 20 years. Applications include coating of orthopedic and dental 
implants, alveolar ridge augmentation, maxillofacial surgery, otolaryngology, and 
scaffolds for bone growth and as powders in total hip and knee surgery (Hench et al., 
1998). 
 
Calcium phosphate has been synthesized and used for manufacturing various 
forms of implants, as well as for solid or porous coatings on other implants. There 
are mono-, di-, tri-, and tetra-calcium phosphates, in addition to the hydroxyapatite 
and β-whitlockite, which have ratios of 5/3 and 3/2 for calcium and phosphorus 
(Ca/P), respectively. The stability in solution generally increases with increasing 
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Ca/P ratios (Park and Lakes, 2007). Different phases are used in different 
applications depending upon whether a degradable or a bioactive material is desired 
(Billotte, 2000). Table 2.7 summarized various phases of calcium phosphate 
currently used in the biomedical industry. 
 
Table 2.7: Various phases of calcium phosphate ceramics (Guelcher and Hooinger, 
2006) 
Phases 
Chemical 
formulae 
Mineral 
name 
Ca/P 
ratio 
Hydroxyapatite (HA) Ca10(PO4)6(OH)2 Apatite 1.67 
α-Tricalcium phosphate (α-TCP) Ca3(PO4)2 Whitlockite 1.5 
β-Tricalcium phosphate (β-TCP) Ca3(PO4)2 Whitlockite 1.5 
Dicalcium phosphate dihydrate 
(DCPD) 
CaHPO4.2H2O Brushite 1.0 
Dicalcium phosphate anhydrous 
(DCPA) 
CaHPO4 Monetite 1.0 
 
The stable phases of calcium phosphate ceramics depend considerably upon 
temperature and the presence of water, either during processing or in the use 
environment. At body temperature, only two calcium phosphates are stable in contact 
with aqueous media, such as body fluids; at pH < 4.2, the stable phase is 
CaHPO4.2H2O (DCPD or brushite, C2P), whereas at pH ≥ 4.2, the stable phase is 
Ca10(PO4)6(OH)2 (HA) [Hench, 1991]. At higher temperatures, other phases, such as 
Ca3(PO4)2 (β-tricalcium phosphate, C3P, or TCP) and Ca4P2O9 (tetracalcium 
phosphate) are present. The unhydrated, high-temperature calcium phosphate phases 
interact with water, or body fluids at 37oC to form HA. Thus, the solubility of a TCP 
surface approaches the solubility of HA and decrease the pH of the solution which 
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further increases the solubility of TCP and enhances resorption (Hench, 1991). The 
presence of micropores in the sintered material can increase the solubility of these 
phases (Jarcho, 1981). 
 
There is a wide variation in the mechanical properties of synthetic calcium 
phosphates, as given in Table 2.8. The mechanical behavior of calcium phosphate 
ceramics strongly influences their application as implants. Tensile and compressive 
strength and fatigue resistance depend on the total volume of porosity. The wide 
variations of properties are due to the variations in the structure of polycrystalline 
calcium phosphates due to variations in the manufacturing processes. Depending on 
the final firing conditions, the calcium phosphate can be calcium hydroxyapatite or 
β-TCP. In many instances, however, both type of structure exist in the same final 
product. 
 
Table 2.8: Physical properties of synthetic calcium phosphates (Park and Lakes, 
2007) 
Properties Values 
Elastic modulus (GPa) 40-117 
Compressive strength (MPa) 294 
Bending strength (MPa) 147 
Hardness (Vickers, GPa) 3.43 
Poisson’s ratio 0.27 
Density (Theoretical, g/cm3) 3.16 
 
           Sintering of calcium phosphate ceramics usually occurs at 1000-1500oC, 
following compaction of the powder into a desired shape. The phase formed at high 
temperature depends not only on temperature but also on the partial pressure of water 
(ρH2O) in the sintering atmosphere. When water is present, HA can be formed and is a 
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stable phase up to 1360oC. Without water, C4P and C3P are stable phases (Hench, 
1991).  
 
The temperature range of HA stability increases with ρH2O, as does the rate of 
phase transitions of C3P or C4P to HA. Because of kinetics barriers that affect the 
rates of formation of the stable calcium phosphate phases, it is often difficult to 
predict the volume fraction of high-temperature phases that are formed during 
sintering and their relative stability when cooled to room temperature. 
 
Starting powders can be made by mixing into an aqueous solution the 
appropriate molar ratios of calcium nitrate and ammonium phosphate which yield a 
precipitate of stoichiometric HA. The Ca2+, PO43- and OH- ions can be replaced by 
other ions during processing or in physiological surroundings; e.g., fluorapatite and 
carbonated apatite. Flourapatite is found in dental enamel and carbornated apatite is 
present in bone (Hench, 1998). 
 
2.3.1  Biological apatite 
Biological apatites constitute the mineral phase of calcified tissue such as 
bone, dentine and enamel in the body and also some pathological calcifications. They 
are similar to synthetic HA but they differ from HA in composition, stoichiometry 
and physical and mechanical properties. Biological apatites are usually calcium-
deficient as a result of various substitution at regular HA lattice points. It is therefore 
not appropriate to simply refer to biological apatite as hydroxyapatite. Table 2.9 
presents the composition of biological apatite and hydroxyapatite. Table 2.10 shows 
the properties of biological apatite and hydroxapatite. 
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Table 2.9: Composition of biological apatite and hydroxyapatite (Donglu Shi, 2004) 
Major constituent Biological apatite Hydroxyapatite 
In enamel (wt%) In bone (wt%) 
Ca 
P 
Na 
K 
Mg 
F 
Cl 
CO32- 
Silicon  
Ca:P (molar ratio) 
36.00 
17.70 
0.50 
0.08 
0.44 
0.01 
0.30 
3.20 
0.003 
1.62 
24.50 
11.50 
0.70 
0.03 
0.55 
0.02 
0.10 
0.58 
0.04 
1.65 
39.60 
18.50 
 
 
 
 
 
 
 
1.67 
 
Table 2.10: Properties of biological apatite and hydroxyapatite (Donglu Shi, 2004) 
Property 
Biological apatite 
Hydroxyapatite 
In enamel In bone 
Lattice parameter / nm 
a 
c 
Crystal size/ nm 
Elastic modulus/ GPa 
Tensile strength/ MPa 
 
 
0.9441 
0.6882 
130x30 
14 
70 
 
0.9419 
0.6880 
25x(2.5-5.0) 
7-30 
50-150 
 
 
0.9423 
0.6875 
in micrometers 
10 
̴ 100 
 
 
 
2.3.2  Hydroxyapatite 
Hydroxyapatite (HA) is the most important among the calcium compounds 
since it is found in natural hard tissues as mineral phase. Among the most interesting 
properties of hydroxyapatite as a biomaterial is its excellent biocompatibility. It 
appears to form a direct chemical bond with hard tissue. In addition, hydroxyapatite 
acts as reinforcement in hard tissues and is responsible for the stiffness of bone, 
dentine, and enamel (Wong and Bronzino, 2007). 
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According to Park and Lake, (1992), the mineral part of bone and teeth is 
made of a crystalline form of calcium phosphate similar to hydroxyapatite. The 
apatite family of mineral crystallizes into hexagonal rhombic prisms, with the space 
group being P63/m and has unit cell dimensions a = 9.432  and c = 6.875 . The 
unit cell contains a complete representation of the apatite crystal, consisting of Ca2+, 
PO43-, and OH- groups closely packed together in arrangement shown in Figure 2.1. 
The atomic structure of hydroxyaptite projected down the c-axis onto the basal plane. 
The hydroxyl ions lie on the corners of the projected basal plane and they occur at 
equidistant interval (3.44 ) along the columns perpendicular to the basal plane and 
parallel to the c-axis. Six of the ten calcium ions in the unit cell are associated with 
the hydroxyls in these columns, resulting in strong interactions among them. 
 
 
 
 
 
 
 
 
Figure 2.1 The atomic arrangement of calcium hydroxyapatite 
(Hench and Wilson, 1993) 
 
The theoretical composition of pure HA is 39.68 wt% Ca and 18.45 wt% P 
with Ca/P molar ratio of 1.667. In dense HA material, variations in Ca/P ratios after 
sintering are reflected by the β-TCP/HA ratios which in turn reflect the purity. If the 
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Ca/P ratio is 1.67, only HA will be observed in the x-ray diffraction. If the Ca/P ratio 
is lower than 1.67, β-TCP and other phases such as tetracalcium phosphate (TTCP) 
will be presented with the HA phase, depending on the temperature and condition of 
sintering. If Ca/P ratio is higher than 1.67, CaO will be present with the HAp phase 
(Hench and Wilson, 1993). 
 
The synthetic HA is used in hard tissue replacement applications since it is 
capable of undergoing bonding osteogenesis and is chemically stable for long periods 
of time in vivo (Kobayashi et al., 2006). However, despite its chemical similarity to 
bone mineral, synthetic HA differs significantly in terms of its microstructure and 
macrostructure to its nearest biological equivalentcortical bone. Cortical bone is a 
composite material with an advanced structure consisting of collagen fibre-HA 
crystallite networks at the molecular level, a lamellar structure at the microstructural 
level and aligned cylindrical units at the macrostructural level (Ruys et al., 1995). At 
present, applications for synthetic HA are restricted to areas free of dynamic load 
bearing because synthetic HA is known for its weakness and brittleness (Zhang et al., 
2003). 
 
Synthetic HA is simply a fine-grained polycrystalline ceramic. This large 
difference in structure accounts for the low fracture toughness of synthetic HA in 
relation to bone: HA ≈ 0.6-1.5 MPa m1/2 ; bone ≈ 2-12 MPa m1/2 (Ruys et al., 1995). 
 
To produce synthetic HA powders with the desired properties, wet-chemical 
methods (precipitation, hydrothermal technique and hydrolysis of other calcium 
phosphates) and dry processes (solid-state reaction) can be used. In general, the wet-
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chemical methods allow the production of materials with good crystallinity, 
physiological stability, and with the morphological characteristics of the hard tissue, 
but some of the physical, chemical, and mechanical properties of the final product 
usually depend on the specific method used in the synthesis (Donadel et al., 2005). 
 
2.3.3  Tricalcium phosphate 
The chemical formula of tricalcium phosphate (TCP) is Ca3(PO4)2. TCP has 
four polymorphs: α, β, γ and super-α. The γ-polymorph phase is a high-pressure 
phase, and the super-α polymorph phase is observed at temperature above 
approximate 1500oC. Therefore the most frequently observed TCP polymorphs in the 
field of bioceramics are: α and β-TCP. β-TCP is table up to 1125oC. But above this 
temperature and up to 1430oC, α-TCP becomes the stable phase. Supper α-TCP 
forms between 1430oC and the melting point 1756oC (Guelcher and Hollinger, 
2006). 
 
TCP is a resorbable temporary bone space filler material. When implanted, 
TCP will interact with body fluids to form HA as follows (Grook, 1984):  
   4Ca3(PO4)2 + 2H2O → Ca10(PO4)6(OH)2 (surface) + 2Ca2+ + 2HPO42-              (2.1) 
This reaction will decrease with the pH of the local solution and further 
increases the solubility of TCP. Theoretically, resorbable TCP is an ideal implant 
material. After implantation, TCP will degrade with time and be replaced with 
natural tissues. It leads to the regeneration of tissues instead of their replacement and 
so solves the problem of interfacial stability. However, in clinical applications, some 
limitations restrict the use of resorbable TCP: 
